|
Vitamin BT (L-carnitine) is a natural energy vitamin which has revolutionised dieting and active health prophylaxis. The pace of life, the passage of years, the environment, and a non-rational diet deplete the physiological stores of vitamin BT. Vitamin BT plays important vital functions of a cytoplasmatic buffer and membrane transporter for acyl and acethyl radicals and ions – reactive forms of nutrients – fats, carbohydrates, amino acids, electrolytes and micro-elements, owing to which, when systematically supplemented: it increases fat burning by 70% - supports weight loss, guarantees the effectiveness of dieting, and makes it possible to stabilise the low weight level; it limits the production of fat and cholesterol and improves glucose tolerance – prevents obesity, cellulite, atherosclerosis and diabetes; it increases the efficiency of energy metabolism processes and regulates mineral balance – accelerates postprandial regeneration and improves aerobic capacity; it eliminates free radicals and stabilises biological membranes – enhances vitality, increases immune resistance, and slows down the ageing processes. Vitamin BT supplementation is recommended for obese persons and persons with a tendency to bodyweight increase, reducing their bodyweight, and at risk of obesity complications - atherosclerosis and diabetes, persons undergoing physical rehabilitation, recreational athletes and high-performance athletes, and everybody who is aged 40 and more. OLIMP L-carnitine Forte Plus (cherry flavoured chewable tablets) - 1 tablet contains 500 mg of pure L-carnitine – it is an almost doubly enhanced formula of OLIMP L-carnitine Plus. It is additionally supplemented with L-arginine, L-ornithine, and chromium – ingredients which enhance the weight reduction and health promoting properties of L-carnitine. The product is indicated mainly for persons with substantial overweight – for rapid weight reduction, and for athletes – for rapid reduction of subcutaneous fat. |
|
|
|
|
This product was added to our catalog on Saturday 29 October, 2005. |
|